S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Realaus laiko atnaujinimai NovaBay Pharmaceuticals [NBY]

Birža: AMEX Pramonė: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

Atnaujinta3 geg. 2024 @ 23:00

5.44% $ 0.0949

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands...

Stats
Šios dienos apimtis 1.46M
Vidutinė apimtis 2.33M
Rinkos kapitalizacija 3.42M
EPS $0 ( 2024-04-04 )
Kita pelno data ( $-0.300 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0200
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-06-09 Freiman Paul E. Buy 858 Restricted Stock Units
2023-06-09 Garlikov Julie Buy 858 Restricted Stock Units
2023-06-09 Zheng Yenyou Buy 858 Restricted Stock Units
2023-06-09 Zheng Yongxiang Buy 858 Restricted Stock Units
2023-06-09 Sit Swan Buy 858 Restricted Stock Units
INSIDER POWER
-54.18
Last 96 transactions
Buy: 2 335 940 | Sell: 2 184 002

Tūris Koreliacija

Ilgas: -0.01 (neutral)
Trumpas: -0.24 (neutral)
Signal:(52.342) Neutral

NovaBay Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

NovaBay Pharmaceuticals Koreliacija - Valiuta/Žaliavos

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.46
( neutral )

NovaBay Pharmaceuticals Finansinės ataskaitos

Annual 2023
Pajamos: $14.73M
Bruto pelnas: $7.90M (53.61 %)
EPS: $-2.29
FY 2023
Pajamos: $14.73M
Bruto pelnas: $7.90M (53.61 %)
EPS: $-2.29
FY 2022
Pajamos: $14.40M
Bruto pelnas: $7.78M (54.02 %)
EPS: $-10.10
FY 2021
Pajamos: $8.42M
Bruto pelnas: $5.65M (67.03 %)
EPS: $-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.